Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-25T06:19:34.643Z Has data issue: false hasContentIssue false

Chapter 54 - Cancer and Paraneoplastic Strokes

from Section 6 - Systemic Disorders That Also Involve the Cerebrovascular System

Published online by Cambridge University Press:  15 June 2018

By
Susana Arias-Rivas ,
Manuel Rodríguez-Yáñez ,
Antonio Dávalos Errando  and
José Castillo
Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 437 - 444
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agnelli, G., George, D. J., Kakkar, A. K., et al. 2012. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med, 366, 601–9.CrossRefGoogle ScholarPubMed
Agnelli, G., Gussoni, G., Bianchini, C., et al. 2009. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study. Lancet Oncol, 10, 943–9.CrossRefGoogle ScholarPubMed
Bang, O. Y., Ovbiagele, B., and Kim, J. S.. 2014. Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke, 45, 1186–94.CrossRefGoogle ScholarPubMed
Baron, J. A., Gridley, G., Weiderpass, E., Nyren, O., and Linet, M.. 1998. Venous thromboembolism and cancer. Lancet, 351, 1077–80.CrossRefGoogle ScholarPubMed
Bennett, C. L., Angelotta, C., Yarnold, P. R., et al. 2006. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA, 296, 2558–60.CrossRefGoogle ScholarPubMed
Bick, R. L. 2003. Cancer-associated thrombosis. N Engl J Med, 349, 109–11.Google Scholar
Buggiani, G., Krysenka, A., Grazzini, M., et al. 2010. Paraneoplastic vasculitis and paraneoplastic vascular syndromes. Dermatol Ther, 23, 597–605.Google Scholar
Caine, G. J., Stonelake, P. S., Lip, G. Y., and Kehoe, S. T.. 2002. The hypercoagulable state of malignancy: Pathogenesis and current debate. Neoplasia, 4, 465–73.Google Scholar
Cestari, D. M., Weine, D. M., Panageas, K. S., Segal, A. Z., and DeAngelis, L. M.. 2004. Stroke in patients with cancer: Incidence and etiology. Neurology, 62, 2025–30.CrossRefGoogle ScholarPubMed
Chaturvedi, P., Singh, A. P., and Batra, S. K.. 2008. Structure, evolution, and biology of the MUC4 mucin. FASEB J, 22, 966–81.Google Scholar
Cheng, S. W., Ting, A. C., and Wu, L. L.. 2002. Ultrasonic analysis of plaque characteristics and intimal-medial thickness in radiation-induced atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg, 24, 499–504.Google Scholar
Chighizola, C. B., Andreoli, L., de Jesus, G. R., et al. 2015. The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature. Lupus, 24, 980–4.Google Scholar
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., et al. 2005. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med, 352, 1305–16.CrossRefGoogle ScholarPubMed
Cramer, S. C., Rordorf, G., Maki, J. H., et al. 2004. Increased pelvic vein thrombi in cryptogenic stroke: Results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke, 35, 46–50.Google Scholar
Dalmau, J. 2009. Recognizing paraneoplastic limbic encephalitis. J Clin Oncol, 27, e230–231; author reply e232.Google Scholar
Dalmau, J. O. and Posner, J. B.. 1997. Paraneoplastic syndromes affecting the nervous system. Semin Oncol, 24, 318–328.Google Scholar
De Stefano, V., Za, T., Rossi, E., et al. 2008. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments. Haematologica, 93, 372–80.Google Scholar
Dorresteijn, L. D., Kappelle, A. C., Boogerd, W., et al. 2002. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol, 20, 282–8.CrossRefGoogle ScholarPubMed
Dowling, N. F., Austin, H., Dilley, A., et al. 2003. The epidemiology of venous thromboembolism in Caucasians and African-Americans: The GATE Study. J Thromb Haemost, 1, 80–7.CrossRefGoogle ScholarPubMed
el-Shami, K., Griffiths, E., and Streiff, M.. 2007. Nonbacterial thrombotic endocarditis in cancer patients: Pathogenesis, diagnosis, and treatment. Oncologist, 12, 518–23.Google Scholar
Graus, F., Rogers, L. R., and Posner, J. B.. 1985. Cerebrovascular complications in patients with cancer. Medicine (Baltimore), 64, 16–35.Google Scholar
Graus, F., Arino, H., and Dalmau, J.. 2014. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood, 123, 3230–8.Google Scholar
Grisold, W., Oberndorfer, S., and Struhal, W.. 2009. Stroke and cancer: A review. Acta Neurol Scand, 119, 1–16.Google Scholar
Hong, C. T., Tsai, L. K., and Jeng, J. S.. 2009. Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging. Cerebrovasc Dis, 28, 411–16.Google Scholar
Hull, R. D., Pineo, G. F., Brant, R. F., et al. 2006. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med, 119, 1062–72.Google Scholar
Hurwitz, H. I., Saltz, L. B., Van Cutsem, E., et al. 2011. Venous thromboembolic events with chemotherapy plus bevacizumab: A pooled analysis of patients in randomized phase II and III studies. J Clin Oncol, 29, 1757–64.Google Scholar
Kase, C. S. 1986. Intracerebral hemorrhage: Non-hypertensive causes. Stroke, 17, 590–5.Google Scholar
Kent, D. M. and Thaler, D. E.. 2010. Is patent foramen ovale a modifiable risk factor for stroke recurrence? Stroke, 4, S26–30.Google Scholar
Kent, D. M., Ruthazer, R., Weimar, C., et al. 2013. An index to identify stroke-related vs. incidental patent foramen ovale in cryptogenic stroke. Neurology, 81, 619–25.Google Scholar
Kim, K. and Lee, J. H.. 2014. Risk factors and biomarkers of ischemic stroke in cancer patients. J Stroke, 16, 91–6.Google Scholar
Kim, S. G., Hong, J. M., Kim, H. Y., et al. 2010. Ischemic stroke in cancer patients with and without conventional mechanisms: A multicenter study in Korea. Stroke, 41, 798–801.CrossRefGoogle ScholarPubMed
Kim, S. J., Moon, G. J., and Bang, O. Y.. 2013. Biomarkers for stroke. J Stroke, 15, 27–37.Google Scholar
Krauth, M. T., Puthenparambil, J., and Lechner, K.. 2012. Paraneoplastic autoimmune thrombocytopenia in solid tumors. Crit Rev Oncol Hematol, 81, 75–81.Google Scholar
Lee, A. Y., Levine, M. N., Baker, R. I., et al. 2003. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med, 349, 146–53.Google Scholar
Mohr, J. P., Thompson, J. L., Lazar, R. M., et al. 2001. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med, 345, 1444–51.Google Scholar
Nagel, M. A. and Gilden, D.. 2015. The relationship between herpes zoster and stroke. Curr Neurol Neurosci Rep, 15, 16.CrossRefGoogle ScholarPubMed
Narvaez, J., Estrada, P., Lopez-Vives, L., et al. 2015. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica. Semin Arthritis Rheum, 45, 328–33.Google Scholar
Navi, B. B., Reichman, J. S., Berlin, D., et al. 2010. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology, 74, 494–501.Google Scholar
Navi, B. B., Singer, S., Merkler, A. E., et al. 2014. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology, 83, 26–33.Google Scholar
Oberndorfer, S., Nussgruber, V., Berger, O., Lahrmann, H., and Grisold, W.. 2009. Stroke in cancer patients: A risk factor analysis. J Neurooncol, 94, 227.Google Scholar
Park, H. J. and Ranganathan, P.. 2011. Neoplastic and paraneoplastic vasculitis, vasculopathy, and hypercoagulability. Rheum Dis Clin North Am, 37, 593–606.Google Scholar
Pelosof, L. C. and Gerber, D. E.. 2010. Paraneoplastic syndromes: An approach to diagnosis and treatment. Mayo Clin Proc, 85, 838–54.Google Scholar
Piatek, C. and O’Connell, C.. 2012. Unsuspected pulmonary embolism: Impact on mortality among cancer patients. Curr Opin Pulm Med, 18, 406–9.CrossRefGoogle ScholarPubMed
Piatek, C., O’Connell, C. L., and Liebman, H. A.. 2012. Treating venous thromboembolism in patients with cancer. Expert Rev Hematol, 5, 201–9.CrossRefGoogle ScholarPubMed
Plummer, C., Henderson, R. D., O’Sullivan, J. D., and Read, S. J.. 2011. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: A review. Stroke, 42, 2410–18.Google Scholar
Quinn, J. A. and DeAngelis, L. M.. 2000. Neurologic emergencies in the cancer patient. Semin Oncol, 27, 311–21.Google Scholar
Reynen, K., Kockeritz, U., and Strasser, R. H.. 2004. Metastases to the heart. Ann Oncol, 15, 375–81.CrossRefGoogle ScholarPubMed
Rogers, L. R. 2010. Cerebrovascular complications in patients with cancer. Semin Neurol, 30, 311–19.Google Scholar
Scalia, G. M., Tandon, A. K., and Robertson, J. A.. 2012. Stroke, aortic vegetations and disseminated adenocarcinoma: A case of marantic endocarditis. Heart Lung Circ, 21, 234–6.CrossRefGoogle ScholarPubMed
Scappaticci, F. A., Skillings, J. R., Holden, S. N., et al. 2007. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst, 99, 1232–9.Google Scholar
Scarpace, S. L., Hahn, T., Roy, H., et al. 2005. Arterial thrombosis in four patients treated with thalidomide. Leuk Lymphoma, 46, 239–42.Google Scholar
Schulman, S., Kearon, C., Kakkar, A. K., et al. 2009. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med, 361, 2342–52.Google Scholar
Seok, J. M., Kim, S. G., Kim, J. W., et al. 2010. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol, 68, 213–19.Google Scholar
Singhal, A. B., Topcuoglu, M. A., and Buonanno, F. S.. 2002. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: A diffusion-weighted magnetic resonance imaging study. Stroke, 33, 1267–73.Google Scholar
Stefan, O., Vera, N., Otto, B., Heinz, L., and Wolfgang, G.. 2009. Stroke in cancer patients: A risk factor analysis. J Neurooncol, 94, 221–6.CrossRefGoogle ScholarPubMed
Taccone, F. S., Jeangette, S. M., and Blecic, S. A.. 2008. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis, 17, 169–74.Google Scholar
Uemura, J., Kimura, K., Sibazaki, K., et al. 2010. Acute stroke patients have occult malignancy more often than expected. Eur Neurol, 64, 140–4.Google Scholar
Ungprasert, P., Sanguankeo, A., Upala, S., and Knight, E. L.. 2014. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: A systematic review and meta-analysis. Semin Arthritis Rheum, 44, 366–70.CrossRefGoogle ScholarPubMed
Varki, A. 2007. Trousseau’s syndrome: Multiple definitions and multiple mechanisms. Blood, 110, 1723–19.Google Scholar
Wasay, M., Bakshi, R., Bobustuc, G., et al. 2008. Cerebral venous thrombosis: Analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis, 17, 49–54.Google Scholar
Younger, D. S. 2004. Vasculitis of the nervous system. Curr Opin Neurol, 17, 317–36.CrossRefGoogle ScholarPubMed
Zhang, Y. Y., Cordato, D., Shen, Q., et al. 2007. Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: A nested case–control study. Cerebrovasc Dis, 23, 181–7.Google Scholar
Zhu, D. S., Fu, J., Zhang, Y., et al. 2014. Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics. J Neurol Sci, 346, 138–44.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×